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ABsTrACT
The effect of Theranekron® on rat ovaries was evaluated in healthy and ischemia-reperfusion injury models. 
The rats were divided into four groups: group 1: control, group 2: Theranekron® (single dose of 0.3 mg/kg 
intraperitoneally), group 3: torsion + detorsion, and group 4: torsion + detorsion + Theranekron® (single dose 0,3 mg/
kg, intraperitoneally). The ovaries were homogenized by sonication before the analysis and supernatant glucose-6-
phosphate dehydrogenase activity, reduced nicotinamide adenine dinucleotide phosphate, reduced glutathione and 
total protein levels were evaluated spectrophotometrically. Ovary tissues were histologically examined. In group 2, 
glucose-6-phosphate dehydrogenase activity was significantly reduced (P<0.01) compared to the control group and 
an increased number of atretic follicles, and hyperaemic and haemorrhagic regions were seen histologically; in group 
3, although glucose-6-phosphate dehydrogenase activity was not changed, intense hyperaemia and hemorrhage was 
observed in the veins of the medulla region and in the cortex. Group 4 showed a decrease in glucose-6-phosphate 
dehydrogenase activity compared to the control group (P<0.01). Histologically, when compared to group 3, group 4 
showed fewer atretic follicles and decreased hyperaemia and hemorrhage in the ovaries, excluding the medulla region. 
There were no significant differences regarding reduced glutathione and reduced nicotinamide adenine dinucleotide 
phosphate levels between the groups. The Theranekron® dose applied had some negative effects, such as reduced 
glucose-6-phosphate dehydrogenase activity, an increased number of atretic follicles, and hyperemia in the corpus 
luteum and medulla region in intact rat ovaries. Although it reduced glucose-6-phosphate dehydrogenase activity, 
Theranekron® may have had slight remedial effects on rat ovaries with ischemia-reperfusion injury. 
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Theranekron® (Richter Pharma, Wels, Austria) 
is a homeopathic remedy prepared from the poison 
of Cuban Tarantulas (Tarentula cubensis). Although 
the mechanism of action of Theranekron® is not 
well defined, it is assumed to stimulate the defense 
mechanisms of the body leading to amelioration 
of such inflammatory lesions (DAY, 1998). It 
is reported that Theranekron® has therapeutic 
properties in uterine involution (KACAR et 
al., 2007), mammary tumors (GULTEKIN and 
VURAL, 2007) and peritoneal wound healing 
(ADIB-HASHEMI et al., 2016), in animals.
We aimed to investigate the possible remedial 
effects of Theranekron® in ovarian torsion-
detorsion, in which there is a markedly extensive 
inflammatory response during ischemia-reperfusion 
(ERGUN et al., 2010; BOSTANCI et al., 2016). 
Therefore, we designed a study in a rat model, to 
investigate the acute effects of Theranekron® on 
intact ovaries and those with induced ischemia-
reperfusion injury. To our knowledge, this is the 
first study to investigate the effects of Theranekron® 
on the activity of G6PD and levels of NADPH and 
rGSH, also by describing histological structures in 
healthy rats and with ischemia-reperfusion injury.
Materials and methods 
Animals. In this study, 38 female, non-pregnant, 
Wistar Albino rats (8-9 weeks-old, 200-250 g/body 
weight) were used. The animals were housed in 
polypropylene cages under standard temperature 
(25 ± 2 °C), laboratory humidity (45 ± 5%), and 
12 h light/dark cycle conditions, and were provided 
with food and water ad libitum for 7 days before 
the experiment. The study was approved by the 
Experimental Animals Ethics Committee (Year 2013 
- No: 12/4) of Hatay Mustafa Kemal University. 
All experiments were performed in compliance 
with international guidelines on the ethical use 
of animals. Theranekron® was purchased from 
Richter Pharma, Wels, Austria. The animals were 
anesthetized with xylazine hydrochloride (7 mg/
kg, The Romper, Bayer Pharmaceutical, Germany) 
and ketamine hydrochloride (60 mg/kg, Ketan’s, 
Eczacibaşi, Pharmaceutical, Turkey) before the 
surgical treatment (LEBOVIC et al., 2004). To 
perform the ovarian torsion in the experimental 
groups Clip Turcica, a malleable, aluminum device 
ıntroduction
Ovaries, in humans and mammals, are complex 
endocrine and exocrine organs that show structural 
and functional changes during the reproductive 
cycle (SAHINARSLAN, 2009). It has been 
reported that the incidence of ovarian torsion 
among emergency gynecological cases is 2.7% 
(HIBBARD, 1985; OELSNER and SHASHAR, 
2006). The rotation of certain parts or all of the 
ovary around the vasculature axis of this organ is 
described as ovarian torsion, eventually leading 
to ischemia, which is an insufficient supply of 
blood to an organ, usually due to a blocked artery 
(PARASHAR and UPPAL, 2011). Although 
complete arterial obstruction does not generally 
occur during tortion, histopathological findings, 
such as congestion, adnexal edema, ischemia and 
necrosis, have been reported (OELSNER and 
SHASHAR, 2006). In recent years, the preferred 
treatment method for ovarian tortion is detorsion 
by surgical intervention. However, mechanical 
detorsion and consequent reperfusion of the ovary 
may have systemic and local consequences due to 
the fact that restoration of blood flow to the organ, 
once compromised by ischemia, leads to more 
severe damage to the tissue than ischemia-induced 
damage (TASKIN et al., 1998; YAZICI et al., 
2007). Furthermore, during the detorsion process, 
an excess amount of molecular oxygen is supplied 
to the tissues, and abundant amounts of reactive 
oxygen species (ROS) are produced, that provoke 
tissue damage (CADIRCI et al., 2010; ERGUN 
et al., 2010). An antioxidant enzyme, glucose-6-
phosphate dehydrogenase (G6PD), regulates the 
pentose phosphate metabolic pathway that supplies 
reducing agents, by maintaining the level of the co-
enzyme reduced nicotinamide adenine dinucleotide 
phosphate (NADPH). Glucose-6-phosphate 
dehydrogenase reduces nicotinamide adenine 
dinucleotide phosphate (NADP+) to NADPH, 
while oxidizing glucose-6-phosphate. The NADPH 
in turn maintains the level of reduced glutathione 
(rGSH) in the cell, which protects cells against 
oxidative damage (SALATI and AMIR-AHMADI, 
2001). It is reported that some antioxidants, such 
as superoxide dismutase, catalase and glutathione 
(GSH), are reduced in ischemia-reperfusion injury 
in rat ovaries (SOYMAN et al., 2017). 
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that facilitates holding and release of the  adnexa 
during a period of experimental ovarian ischemia 
and reperfusion, was used (HASCALIK et al., 
2005, ERGUN et al., 2010). 
On the basis of the experimental treatment, the 
animals were divided into four groups. Group 1 
(Control): Rats whose ovaries were removed under 
anesthesia without being subject to any treatment. 
Group 2 (Theranekron®): Rats whose ovaries 
were removed three hours later after a single 
dose of Theranekron® (0.3 mg/kg, intraperitoneal) 
administered under anesthesia. Group 3 (Torsion-
detorsion): Rats whose ovaries were torsioned 
Biochemical analysis. The ovaries were 
dissected, cleaned in ice-cold saline (0.9%, w/v), 
pat dried on filter paper, weighed, and stored at -86o 
C in aluminum foil until analysis. Before analysis, 
the ovaries were sliced in 2 mL transparent, 
polyethylene tubes (1.5 cm in diameter, 6 cm in 
lenght) and sonicated on ice in phosphate buffered 
solution on a continuous basis, by SONIC vibra 
cells (Bandelin Sonopuls HD 2070, Germany) 
5 times for 10 seconds, a with 30 second cooling 
period between (AKALIN PEKER et al., 2016). 
The homogenate was centrifuged at 13000g 15 
min/+4o C, and the supernatant was used for 
spectrophotometrical (UV 2100 UV-VIS Recording 
Spectrophotometer Shimadzu, Japan) analysis 
of G6PD activity, rGSH and total protein levels. 
Supernatant NADPH levels were determined by 
an ELISA reader (BioTek Instruments, µQuant, 
U.S.A), with a microplate (Greiner bio-one Italia, 
Cellstar, Italy).
Determination of glucose-6-phosphate 
dehydrogenase activity. The G6PD activity was 
determined spectrophotometrically at 25o C, as 
described by BEUTLER (1971). Briefly, the enzyme 
sample was added to the 1mL of (final volume) 
incubation mixture containing 100 µL 1 M Tris-
HCl-EDTA (pH 8.0) + 100 µL 0,1 mol/L MgCl2, 
100 µL 2 mM NADP+ and 100 µL 6 mM glucose-6 
phosphate, distilled water and the supernatant. The 
activity measurement was monitored by the increase 
in absorption at 340 nm due to the reduction of 
NADP+. Results are presented as IU/g protein. 
Determination of reduced glutathione levels. 
rGSH levels were analyzed according to ELLMAN’s 
(1959) method. It is a kinetic method based on 
the principle of the reduction of 5.5'-dithiobis 
(2-nitrobenzoic) acid to trinitrobenzoat by 
glutathione. The optical density of the reduced di-
sulphide compound absorbance can be measured by 
spectrophotometry at 412 nm. Results are presented 
as µmol/g protein. 
Determination of NADPH levels. NADPH 
levels in the supernatants were determined 
colorimetrically using a commercial kit (MAK038, 
Sigma-Aldrich, Germany). The reaction principle is 
based on the colorimetric analysis of the reduction 










Group 1 8 - - - -
Group 2 10 0.3 mg/kg 3 hours - -
Group 3 10 - - 3 hours 3 hours
Group 4 10 0.3 mg/kg 3 hours 3 hours 3 hours
Fig. 1. Torsion-detorsion process by Clip Turcica  
(Ergün et al., 2010).
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in the formazan dye by NADPH at 565 nm, which is 
synthesized enzymatically in the pentose phosphate 
pathway. Results are presented as µmol/g protein.
Determination of protein levels. Quantitative 
protein determination was obtained by absorbance 
measurement at 595 nm according to Bradford, with 
bovine serum albumin as a standard (BRADFORD, 
1979). Results are presented as mg/wet tissue.
Histological analysis. Tissue samples were fixed 
rapidly with 10% buffered formaldehyde following 
macroscopic evaluation. Tissue samples were 
then passed through an alcohol and xylene series 
for dehydration and fixation, following a standard 
protocol, and 4-5 µm paraffin block sections were 
stained with Crossman’s modified triple stain 
(MULISCH and WELSCH, 2010) and examined 
under a CX21 Olympus binocular light microscope 
(Olympus corporation, Japan).
Statistical analysis. All the biochemical values 
were expressed as mean ± standard error. The 
results of the groups were analyzed by ANOVA, 
with a posthoc Duncan test (SPSS for Windows, 
release 23.0). A difference of P<0.05 was considered 
significant.
results
Biochemical findings. G6PD activity was 
significantly lower (P<0.01) in group 2 compared 
to group 1. Group 4 showed non-significantly lower 
G6PD activity compared to group 3 (P>0.05), but 
significantly lower activity compared to group 1 
(P<0.01). Regarding total protein levels, there was 
a significant increase in total protein levels in group 
4 when compared to group 2 (P<0.05). There were 
no significant changes in rGSH and NADPH levels 
between the groups (Table 2). 
Table 2. The effects of Theranekron® on G6PD, NADPH, rGSH and total protein levels in rat ovaries, intact and 










Group 1 8 685.11 ± 93.79 a 26.58 ± 2.59 3.95 ± 0.89 3.46 ± 0.33 ab
Group 2 10 317.65 ± 61.01 b 23.76 ± 2.25 2.64 ± 0.25 3.18 ± 0.26 a
Group 3 10 391.76 ± 98.90 ab 20.13 ± 2.95 2.61 ± 0.15 3.59 ± 0.29 ab
Group 4 10 156.48 ± 29.89 b 21.86 ± 2.72 3.94 ± 0.25 4.63 ± 0.62 b
P P <0.01 - - P <0.05
Means within rows without common superscripts differ significantly (a,b P <0.05). Group 1 - Control, Group 2 - Theranekron®, 
Group 3 - Torsion-Detorsion, Group 4 - Torsion-Detorsion + Theranekron® groups
Histological findings. The ovarian sections, 
germinative epithelium, follicles, corpus luteum 
and vascular structures in the medulla region taken 
from the control group demonstrated organ specific 
histological structures (Fig. 2). In group 2, the tissue 
integrity was maintained and there was no sign of 
germinative epithelium degradation. An increased 
number of atretic follicles and hyperemia of the 
medulla region were observed. In the cortical area, 
hemorrhage of the corpus luteum and hyperemia in 
corpus luteum veins was detected. Moreover, when 
compared to control group, an increase in interstitial 
cells was observed (Fig. 3).
In group 3, in general, there was no change 
in tissue integrity. However, local degerenation 
was observed in the structure of the germinative 
epithelium compared to the control and 
Theranekron® groups. Intense hyperemia and 
hemorrhage were observed in the veins of the 
medulla region, on the follicles surrounding the 
cortex, in the interstitium and the corpus luteum. 
When compared to the control group, similar to the 
Theranekron® group, an increase in the number of 
atretic follicles was observed in group 3 (Fig. 4). 
In group 4, when compared with group 3, similar 
findings were observed of preservation of tissue 
T. Kozlu et al.: Glucose-6-phosphate dehydrogenase activity in the ovaries of Theranekron®  administered rats
Vet. arhiv 91 (1), 81-88, 2021 85
Fig. 2. Triple staining method of rat ovarian section 
from the control group; CL - corpus luteum, v -vessel, 
GF - graaf follicle, m - medulla, v - vein 
Fig. 3. Triple staining method of rat ovarian section 
from Group 2 (Theranekron®). CL - Corpus Luteum; 
hyperemia, m - medulla; hyperemia in the veins of the 
medulla region, v - vein,*; arrow - germinal epithelium.
Fig. 4. Triple staining method of rat ovarian section 
from Group 3 (Torsion-Detorsion). CL - Corpus 
Luteum; hemorrhage, SF - secondary follicle, F - 
follicle; increased number of atretic follicles, v - vein; 
intense hyperemia and hemorrhage in the veins of the 
medulla region, arrow - germinal epithelium; local 
degeneration. 
Fig. 5. Triple staining method of rat ovarian section 
from Group 4 (Torsion - Detorsion + Theranekron®). CL 
- corpus luteum; hemorrhage, m - medulla; hyperemia 
and hemorrhage in the veins of the medulla region, v - 
vein; hyperemia, IC - intersititel cells.  
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integrity. However, fewer atretic follicles were 
observed. Generally, there was a slight reduction in 
hyperemia and hemorrhage, except in the medulla 
in comparison with the regions mentioned in group 
3, but the intensity of hyperemia in the medulla was 
at the same level as in group 3. At the same time, a 
slight decrease in degeneration and the amount of 
connective tissue in interstitial regions was present 
(Fig. 5).
Discussion
Theranekron® is a homeopathic remedy for 
the treatment of lesions in the mouth, hoof and 
endometrium in veterinary medicine (STAMPA, 
1986; ORYAN et al., 2012; DOLAPCIOGLU et al., 
2013; ADIB-HASHEMI et al., 2016). However, our 
literature search did not reveal any study regarding 
the effects of Theranekron® on healthy tissues. Only 
the unchanged serum aspartate amino transferase and 
gamma-glutamyl transferase activities suggested 
that Theranekron® did not have any adverse effects 
on the liver in healthy horses (SARDARI et al., 
2011). In this study, Theranekron® administration to 
healthy rats significantly decreased ovarian G6PD 
activity and caused hemorrhage and hyperemia in 
the corpus luteum and in the veins of the medulla 
region, histologically. Biochemical and histological 
results suggested that Theranekron® may have 
some degenerative effects on intact rat ovaries and 
no anabolic effects.
Ovarian torsion, a gynecological syndrome that 
occurs mostly in adolescent girls and women before 
menopause (HIBBARD, 1985; OELSNER and 
SHASHAR, 2006), will cause venous obstruction, 
bleeding and eventually necrosis of the ovarian 
tissues. Even though the traditional treatment 
has been oophorectomy for these cases, recent 
literature contains cases of conservative therapy 
based on detorsion of the twisted adnexa, which 
has become popular (TASKIN et al., 1998; YAZICI 
et al., 2007). However, recirculation of the ovary 
after detorsion causes a pathophysiological event 
known as “reperfusion injury”. During reperfusion 
injury, systemic and local consequences due to 
the restoration of blood flow and excess amounts 
of ROS, lead to severe tissue damage (CADIRCI 
et al., 2010; ERGUN et al., 2010). Thus, in this 
study, we investigated the remedial effects of 
Theranekron®, which is a homeopathic remedy, on 
ischemia-reperfusion injury induced in rat ovaries. 
Our histological findings in the torsion-detorsion 
group, such as intense hyperemia and hemorrhages 
in the medulla and cortex, and structures of the 
corpus luteum, were compatible with the result of 
BOSTANCI et al., (2016), who showed extensive 
vascular congestion, hemorrhage, and edema in 
torsion-detorsion injury in rat ovaries. However, 
antioxidants, such as G6PD activity, NADPH and 
rGSH levels, were not changed. On the other hand, 
oxidative stress may be increased in ischemia-
reperfusion injury, in that lipid peroxidation (LPO) 
and/or malondialdehyde (MDA) levels increased 
after torsion-detorsion in rat ovaries (ERGUN et al., 
2010). These findings suggest that, increased LPO/
MDA levels in torsion-detorsion may be related to 
other antioxidants rather than G6PD, NADPH and 
rGSH, and possibly lead to tissue degeneration. 
In the study, Theranekron® reduced G6PD 
activity not only in intact ovaries but also in 
ischemia-reperfusion injury. Also, in these animals, 
NADPH levels were unchanged despite the 
G6PD activity reduced by Theranekron®. ROSA 
et al. (2012), suggested that reduced G6PD and 
unchanged 6-phosphogluconate dehydrogenase 
(6PGD) activity would impair NADPH production 
in rat brain cells, but they did not determine 
NADPH levels. Hence, we speculate that cells 
have other NADPH producing enzymes, such as 
6PGD, cytoplasmic isocitrate dehydrogenase, or 
malic enzyme (FLINT and DENTON, 1970) to 
maintain oxidative balance. Given the preserved 
NADPH and rGSH levels and from the histological 
findings (fewer atretic follicles, a slight reduction in 
hyperemia and hemorrhage except in the medulla 
region, and a slight decrease in degeneration and 
the amount of connective tissue in interstitial 
regions), we may argue that ovary tissues may be 
slightly protected by the Theranekron® dose applied 
in the torsion-detorsion process. However, detailed 
experimental studies are needed to elucidate the 
optimum remedial dose of Theranekron® for 
ischemia-reperfusion injury in rat ovaries. 
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Conclusion
Biochemical and histological findings in rat 
ovaries with intact and ischemia-reperfusion injury 
showed that, the Theranekron® dose applied may 
have some degenerative effects on intact ovaries, 
and may have some remedial effects on ischemia-
reperfusion injury in ovaries. Detailed experimental 
studies are needed to elucidate the optimum 
remedial dose of Theranekron® on ischemia-
reperfusion injury in rat ovaries. 
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Kozlu, T., F. GülEr, P. PEKEr AKAlın, F. KAzAK, Y. ErGün, E. AslAn: utjecaj Theranekrona® 
na aktivnost glukoza-6-fosfat dehidrogenaze u neoštećenim jajnicima štakora i jajnicima štakora s ishemijsko-
reperfuzijskom ozljedom. Vet. arhiv 91, 81-88, 2021.
sAžETAK
Učinak Theranekrona® na jajnike štakora procijenjen je u zdravih jedinki i onih s ishemijsko-reperfuzijskom 
ozljedom. Štakori su podijeljeni u četiri skupine: prva je skupina bila kontrolna, druga je skupina dobivala 
Theranekron® (pojedinačna doza od 0,3 mg/kg intraperitonealno), treća je skupina imala torziju i detorziju, a četvrta 
je skupina imala torziju i detorziju i primala je Theranekron® (pojedinačna doza od 0,3 mg/kg intraperitonealno). 
Jajnici su homogenizirani sonikacijom prije analize te je spektrofotometrijom istražena aktivnost supernatant glukoza-
6-fosfat dehidrogenaze, smanjenje nikotinamid-adenin-dinukleotid-fosfata, smanjenje glutationa i razina ukupnih 
proteina. Histološki je analizirano tkivo jajnika. U drugoj skupini aktivnost glukoza-6-fosfat dehidrogenaze bila je 
znakovito smanjena (P < 0,01) u usporedbi s kontrolnom skupinom. Histološki, ustanovljen povećan broj atretskih 
folikula te hiperemičnih i hemoragičnih područja. U trećoj skupini, iako aktivnost glukoza-6-fosfat dehidrogenaze 
nije bila promijenjena, u venama medularne regije i korteksu uočena je jaka hiperemija i hemoragija. Četvrta skupina 
pokazala je smanjenu aktivnost glukoza-6-fosfat dehidrogenaze u usporedbi s kontrolnom skupinom (P < 0,01). U 
usporedbi s trećom skupinom, četvrta skupina pokazala je manje atretskih folikula i smanjenu hiperemiju i hemoragiju 
u jajnicima, osim medularne regije. Nije bilo znakovite razlike s obzirom na smanjene razine glutationa i nikotinamid-
adenin-dinukleotid-fosfata među skupinama. Primijenjena doza Theranekrona® imala je neke negativne učinke poput 
smanjene aktivnosti glukoza-6-fosfat dehidrogenaze, povećanog broja atretskih folikula te hiperemije u žutom tijelu 
i medularnoj regiji intaktnih jajnika štakora. Iako je smanjio aktivnost glukoza-6-fosfat dehidrogenaze, Theranekron® 
bi mogao imati i neznatne terapijske učinke na jajnike štakora s ishemijsko-reperfuzijskom ozljedom. 
Ključne riječi: Theranekron®; jajnik; ishemija-reperfuzija; glukoza-6-fosfat dehidrogenaza; štakor_____________________________________________________________________________________________
